Spirit Airlines' Operational Meltdown Signals the End of Ultra-Low-Cost Flying
Spirit's second bankruptcy in under a year, combined with 10%+ daily cancellation rates, marks a potential death knell for the ultra-low-cost carrier model in America.
TRENDING TOPICS
244 articles found for "savings"
Spirit's second bankruptcy in under a year, combined with 10%+ daily cancellation rates, marks a potential death knell for the ultra-low-cost carrier model in America.
Federal regulators are intensifying scrutiny of Bitcoin ATMs after Americans lost more than $330 million to scams routed through the machines in 2025.
With the $7,500 federal EV tax credit gone, Tesla introduces cheaper Model 3 and Model Y Standard versions starting at $36,990 to compete with Chinese rivals.
Meta eliminated 600 positions across its AI divisions—including the legendary FAIR research unit—while simultaneously hiring for its superintelligence lab. The strategy reveals how AI development is evolving.
Wall Street projects S&P 500 profit margins will hit 13.9% in 2026—the highest in history. Here's what's driving the earnings expansion and what it means for stocks.
Micron can only meet 55% of customer demand as AI devours memory chip supply. PC makers warn of 15-20% price hikes as the shortage spreads from data centers to consumer devices.
SoFi Technologies is on the verge of joining the S&P 500 index, a milestone that could trigger billions in passive fund buying and validate the fintech revolution.
The GENIUS Act created the first comprehensive federal framework for dollar-backed stablecoins. With a $250 billion market, here's what the new rules mean for investors.
With inflation stuck above 2.8% and tariffs adding price pressures, the Fed may hold rates steady through spring. What this means for markets and your portfolio.
From Macy's 150 locations to Kroger's 60 supermarkets, major retailers announce sweeping closures for 2026. What the retail reshaping means for consumers and investors.
Beijing unveils massive stimulus package including $9 billion in consumer subsidies as policymakers confront persistent demand weakness and deflationary pressures.
Novo Nordisk launches oral Wegovy at $149/month as the pharmaceutical giant fights to reclaim ground lost to Eli Lilly in the $100 billion weight-loss drug market.